JAMES HAWKINS - 26 Nov 2021 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ James Hawkins
Issuer symbol
IRMD
Transactions as of
26 Nov 2021
Net transactions value
-$783,863
Form type
4
Filing time
30 Nov 2021, 17:45:37 UTC
Previous filing
24 Nov 2021
Next filing
09 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Award $6,411 +4,332 +25% $1.48* 21,600 26 Nov 2021 Direct F1
transaction IRMD Common Stock Sale $190,608 -4,332 -20% $44.00 17,268 26 Nov 2021 Direct
transaction IRMD Common Stock Award $18,020 +12,176 +71% $1.48* 29,444 29 Nov 2021 Direct F1
transaction IRMD Common Stock Sale $561,435 -12,176 -41% $46.11 17,268 29 Nov 2021 Direct F2
transaction IRMD Common Stock Award $1,860 +1,257 +7.3% $1.48* 18,525 30 Nov 2021 Direct F1
transaction IRMD Common Stock Sale $58,112 -1,257 -6.8% $46.23 17,268 30 Nov 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Stock Options (Right to Buy) Options Exercise $0 -4,332 -9.3% $0.000000 42,176 26 Nov 2021 Common Stock 4,332 $1.48 Direct F1
transaction IRMD Stock Options (Right to Buy) Options Exercise $0 -12,176 -29% $0.000000 30,000 29 Nov 2021 Common Stock 12,176 $1.48 Direct F1
transaction IRMD Stock Options (Right to Buy) Options Exercise $0 -1,257 -4.2% $0.000000 28,743 30 Nov 2021 Common Stock 1,257 $1.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2 This transaction was executed in multiple trades at prices ranging from $44.44 to $46.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $46.20 to $46.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.